Atezolizumab

Red

Brand Name(s):Tecentriq

Indication:Urothelial carcinoma (locally advanced or metastatic )
Lung cancer- metastatic non-squamous non-small cell lung cancer (NSCLC). should be used in combination therapy (bevacizumab, paclitaxel and carboplatin)

Rationale:1,2,3

Considered:Oct-17

Review Date:Mar-24

Comments: